Specialised evaluation and surgical treatment planning for stomach cancer based on tumor location, stage, pathology and overall health.
Gastric cancers can develop in different parts of the stomach and may require a combination of surgery, chemotherapy, immunotherapy, targeted treatment or other approaches depending on the individual case.
Gastric cancer is a cancer that starts in the cells lining the stomach. Most stomach cancers are adenocarcinomas, although other less common tumor types can also occur.
The location of the tumor within the stomach, the depth of invasion, lymph-node involvement and possible spread to other organs all influence the treatment approach.
For selected patients, surgery may involve removal of part or all of the stomach together with appropriate lymph-node assessment. Additional treatment may be considered before or after surgery.
The surgical approach is selected according to tumor location, stage, pathology, resectability and the patient's overall clinical condition.
The stomach has several anatomical regions, and the tumor's location helps determine the extent and type of surgical treatment that may be appropriate.
The cardia is the upper part of the stomach near the junction where the esophagus enters the stomach. Tumors in this region may require specialised surgical planning.
Tumors involving the upper or central stomach are evaluated according to their size, depth, spread and relationship with nearby structures.
The antrum is the lower portion of the stomach. Tumor location here can influence whether a distal or subtotal gastrectomy may be considered.
Tumors close to the pylorus may affect the passage of food into the small intestine and require detailed assessment before treatment.
Pathology helps determine the exact type and biological characteristics of the tumor, which can influence treatment planning.
Adenocarcinoma begins in gland-forming cells within the stomach lining and accounts for the great majority of stomach cancers.
Cardia cancers develop in the upper portion of the stomach near the gastroesophageal junction and may require specialised assessment.
Non-cardia gastric cancers arise in other parts of the stomach and may involve the body, antrum or pyloric region.
Some gastric adenocarcinomas have a diffuse growth pattern and may behave differently from intestinal-type tumors.
Less common tumors can also arise in the stomach, and their treatment may differ from that of gastric adenocarcinoma.
Early stomach cancer may cause few or nonspecific symptoms. Persistent or unexplained symptoms should be medically evaluated.
Ongoing indigestion or discomfort in the upper abdomen may occur and should be evaluated when persistent.
Persistent pain, discomfort or a feeling of fullness in the upper abdomen may occur.
Feeling full after eating a relatively small amount of food can occur in some patients.
Unintentional weight loss may occur and requires evaluation when persistent or unexplained.
Nausea or vomiting may occur, particularly when tumor growth affects the normal passage of food.
Gastric tumors can sometimes bleed, which may contribute to anemia or other signs of blood loss.
Gastric cancer evaluation commonly involves endoscopic assessment and biopsy, followed by imaging and other staging investigations when appropriate.
The goal is to understand the tumor's depth, lymph-node involvement and whether there is disease outside the stomach.
Treatment planning depends on the confirmed pathology, tumor stage, location and overall clinical assessment.
Endoscopy allows direct examination of the stomach lining and helps identify suspicious areas that may require biopsy.
A tissue biopsy is examined to establish the diagnosis and identify the pathological characteristics of the tumor.
CT imaging can help assess the primary tumor, lymph nodes and possible spread to other parts of the body.
PET-CT may be considered in selected patients when additional information about possible distant disease is required.
Endoscopic ultrasound may help assess the depth of tumor involvement and nearby lymph nodes in selected cases.
In selected patients, staging laparoscopy may be considered to look for disease within the abdominal cavity that may not be apparent on routine imaging.
For selected resectable gastric cancers, surgery may involve removing part or all of the stomach together with appropriate regional lymph-node assessment.
When the tumor location and extent allow, only the affected part of the stomach may be removed, preserving the remaining stomach where appropriate.
For selected tumors involving a large or unfavourable portion of the stomach, removal of the entire stomach may be considered.
The surgical technique depends on tumor location, stage, anatomy, planned operation and the patient's overall condition.
Open surgery may be appropriate for selected patients, particularly when the extent or anatomy of disease requires conventional access.
Minimally invasive laparoscopic surgery may be considered for selected gastric cancer procedures when appropriate.
Robotic-assisted surgery may be considered for selected gastric procedures when the anatomy, tumor characteristics and planned operation are suitable.
Appropriate regional lymph-node assessment and removal form an important part of oncological gastric surgery when indicated.
For carefully selected very early gastric cancers, endoscopic treatment may sometimes be considered instead of conventional surgery.
EMR uses an endoscope to remove selected superficial tumors from the stomach lining without conventional abdominal surgery.
ESD is a more extensive endoscopic technique that may be considered for selected early gastric cancers where appropriate.
Endoscopic treatment is only suitable for selected early tumors with a sufficiently low risk of lymph-node spread.
Depending on the stage and biological characteristics of the cancer, treatment may involve therapy before surgery, surgery itself and additional treatment after surgery.
Confirm the diagnosis and establish the location, depth and extent of the gastric cancer.
Selected patients may receive chemotherapy or other systemic treatment before surgery.
The appropriate extent of gastric resection and lymph-node surgery is planned according to the individual tumor.
Follow-up and additional treatment are planned according to the final pathology and clinical findings.
The treatment combination depends on cancer stage, pathology, biomarker findings and overall health.
Chemotherapy may be given before or after surgery or used as part of treatment when surgery is not appropriate.
Selected gastric cancers may be treated with immunotherapy depending on tumor characteristics and treatment setting.
Biomarker testing may help identify patients who could be candidates for specific targeted treatments.
Radiation may have a role in selected gastric cancer treatment plans depending on the stage and clinical situation.
When gastric cancer has spread widely or cannot be safely removed, treatment generally focuses on controlling disease and managing symptoms.
Chemotherapy, immunotherapy or targeted treatment may be considered according to tumor biomarkers, stage and the patient's clinical condition.
Selected procedures may help relieve problems such as obstruction or bleeding when the cancer cannot be completely removed.
Dr. Nitin Singhal is a surgical oncologist in Ahmedabad with experience in gastrointestinal cancer surgery and complex oncological procedures.
For patients with gastric cancer, treatment planning involves reviewing the pathology, tumor location, imaging, stage and overall health before deciding whether surgery and which type of surgery may have a role.
Patients looking for a gastric cancer surgeon in Ahmedabad can undergo a detailed evaluation to understand the tumor location, pathology, stage and available treatment options.
Stomach cancer may develop in different regions of the stomach. Most gastric cancers are adenocarcinomas, and treatment planning depends on the depth of tumor invasion, lymph-node involvement and whether the cancer has spread.
For selected resectable cancers, gastric cancer surgery may involve removal of part or all of the stomach with appropriate lymph-node assessment. Depending on the individual case, laparoscopic or robotic approaches may also be considered.
Patients searching for stomach cancer treatment in Ahmedabad can discuss their endoscopy, biopsy, imaging and other reports with a surgical oncologist to understand whether surgery may have a role in their treatment.
Common questions about gastric cancer diagnosis, surgery and treatment.
Gastric cancer, also called stomach cancer, is cancer that begins in the cells lining the stomach. Most stomach cancers are adenocarcinomas.
Gastric cancer can develop in different parts of the stomach, including the cardia, fundus, body, antrum and pyloric region. The location can influence the surgical approach.
Symptoms may include persistent indigestion, upper abdominal discomfort, early fullness, nausea, vomiting, unexplained weight loss or bleeding. Early gastric cancer can sometimes cause few symptoms.
No. Treatment depends on the cancer stage, location, pathology, resectability and overall health. Surgery may be appropriate for selected resectable cancers, while other patients may require systemic or other treatments.
Gastrectomy is surgery to remove part or all of the stomach. A partial or subtotal gastrectomy removes part of the stomach, while a total gastrectomy removes the entire stomach.
Minimally invasive laparoscopic or robotic-assisted surgery may be considered for selected gastric cancer procedures when the tumor characteristics, anatomy and planned operation are suitable.
Some carefully selected very early gastric cancers may be suitable for endoscopic procedures such as endoscopic mucosal resection or endoscopic submucosal dissection. Suitability depends on specific tumor characteristics.
Some patients receive chemotherapy or other systemic treatment before surgery, while others may receive additional treatment after surgery. The sequence depends on the stage and individual clinical situation.
Evaluation may include upper GI endoscopy with biopsy, CT imaging and, in selected cases, PET-CT, endoscopic ultrasound or staging laparoscopy.
Get a personalised evaluation to understand your diagnosis, tumor location, stage and whether surgery may have a role in your treatment.
Dr. Nitin Singhal has been recognised for his contribution to cancer care and surgical oncology, reflecting his commitment to advanced surgical techniques, clinical excellence and patient-centred care.
Surgical oncology training from Tata Memorial Hospital, Mumbai.
Expertise across complex and multidisciplinary cancer surgery.
Honoured for excellence in healthcare and surgical oncology.
Focus on evidence-based and personalised cancer treatment.
Recognition that reflects a continued commitment to excellence in cancer care.
